Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Illumina stock
Learn how to easily invest in Illumina stock.
Illumina Inc (ILMN) is a leading diagnostics & research business based in the US. It opened the day at $382.61 after a previous close of $384.24. During the day the price has varied from a low of $380.15 to a high of $385.95. The latest price was $380.44 (25 minute delay). Illumina is listed on the NASDAQ and employs 7,800 staff. All prices are listed in US Dollars.
How to buy shares in Illumina
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ILMN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- ILMN shares summary
- Compare share dealing platforms
- Is ILMN stock a buy or sell?
- Stock performance over time
- Is ILMN suitable for ethical investing?
- Are ILMN shares over-valued?
- Illumina's financials
- How volatile are ILMN shares?
- Does Illumina pay a dividend?
- Have ILMN shares ever split?
- Other common questions
Illumina stock price (NASDAQ: ILMN)Use our graph to track the performance of ILMN stocks over time.
Illumina shares at a glance
|52-week range||$341.03 - $555.77|
|50-day moving average||$380.20|
|200-day moving average||$423.79|
|Wall St. target price||$429.94|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$6.11|
Buy Illumina shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Illumina stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Illumina price performance over time
|1 week (2022-01-14)||-6.10%|
|1 month (2021-12-22)||0.43%|
|3 months (2021-10-22)||-7.02%|
|6 months (2021-07-22)||-21.80%|
|1 year (2021-01-22)||-6.35%|
|2 years (2020-01-22)||14.94%|
|3 years (2019-01-22)||25.30%|
|5 years (2017-01-20)||138.16%|
Is Illumina stock undervalued or overvalued?
Valuing Illumina stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Illumina's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Illumina's P/E ratio
Illumina's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 66x. In other words, Illumina shares trade at around 66x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Illumina's PEG ratio
Illumina's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9513. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Illumina's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Illumina's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $918 million.
The EBITDA is a measure of a Illumina's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.3 billion|
|Operating margin TTM||16.5%|
|Gross profit TTM||$2.2 billion|
|Return on assets TTM||3.93%|
|Return on equity TTM||11.86%|
|Market capitalisation||$63.3 billion|
TTM: trailing 12 months
Illumina's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Illumina.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Illumina's total ESG risk score
Total ESG risk: 9.18
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Illumina's overall score of 9.18 (as at 12/31/2018) is excellent – landing it in it in the 2nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Illumina is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Illumina's environmental score
Environmental score: 2.22/100
Illumina's environmental score of 2.22 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Illumina's social score
Social score: 2.6/100
Illumina's social score of 2.6 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Illumina's governance score
Governance score: 5.36/100
Illumina's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Illumina is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Illumina's controversy score
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Illumina scored a 1 out of 5 for controversy – the highest score possible, reflecting that Illumina has managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||9.18|
|Total ESG percentile||2.42|
|Environmental score percentile||2|
|Social score percentile||2|
|Governance score percentile||2|
|Level of controversy||1|
Illumina share dividends
We're not expecting Illumina to pay a dividend over the next 12 months.
Have Illumina's shares ever split?
Illumina's shares were split on a 2:1 basis on 22 September 2008. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Illumina shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Illumina shares which in turn could have impacted Illumina's share price.
Illumina share price volatility
Over the last 12 months, Illumina's shares have ranged in value from as little as $341.03 up to $555.77. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Illumina's is 0.887. This would suggest that Illumina's shares are less volatile than average (for this exchange).
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc.
Illumina in the news
Are Illumina and Beam Therapeutics the Healthcare Industry's Rising Stars?
Bradley & Co. Private Wealth Management, LLC Buys iShares iBonds Dec 2030 Term Corporate ...
Telos Capital Management, Inc. Buys Illumina Inc, United Parcel Service Inc, Newell Brands Inc, ...
Frequently asked questionsWhat percentage of Illumina is owned by insiders or institutions?
Currently 0.328% of Illumina shares are held by insiders and 87.914% by institutions. How many people work for Illumina?
Latest data suggests 7,800 work at Illumina. When does the fiscal year end for Illumina?
Illumina's fiscal year ends in December. Where is Illumina based?
Illumina's address is: 5200 Illumina Way, San Diego, CA, United States, 92122 What is Illumina's ISIN number?
Illumina's international securities identification number is: US4523271090 What is Illumina's CUSIP number?
Illumina's Committee on Uniform Securities Identification Procedures number is: 452327109
More guides on Finder
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
How to buy Specialty Building Products (SBP) stock when it goes public
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
How to buy HeartCore Enterprises (HTCR) stock when it goes public
Everything we know about the HeartCore Enterprises IPO, plus information on how to buy in.
Ask an Expert